XML 42 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Revenue Recognition (Details Textual) - USD ($)
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Jun. 30, 2016
Revenue Recognition [Line Items]      
Revenue, Net, Total $ 698,000 $ 466,000  
Deferred Revenue     $ 426,000
License and Maintenance Revenue 0 $ 21,000  
KOREA, REPUBLIC OF | Korean Pharmaceutical Company [Member]      
Revenue Recognition [Line Items]      
Deferred Revenue $ 500,000    
Deferred Revenue Recognition Period 10 years    
CANADA | Canadian Based Supplier [Member]      
Revenue Recognition [Line Items]      
Deferred Revenue $ 250,000    
Deferred Revenue Recognition Period 7 years